Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease [Letter]

ArticleinNeurology 47(4):1085-7 · November 1996with2 Reads
Impact Factor: 8.29 · DOI: 10.1212/WNL.50.4.1196 · Source: PubMed

    Abstract

    We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased significantly during treatment, and there was no worsening of extrapyramidal symptoms. These results suggest that olanzapine is a well-tolerated and effective treatment for drug-induced psychosis in nondemented patients with Parkinson's disease.